Aya A Mohammed
Researcher
Also affiliated: University of Technology - Iraq (2021–2022)
Unknown Researcher
Research Areas
Biomedical Subjects
Biography and Research Information
OverviewAI-generated summary
Aya A Mohammed's research investigates the role of myeloid cells in ischemic retinopathies, examining recent advancements and ongoing questions in the field. Her work also explores the metabolic reprogramming and angiogenesis mediated by HDAC3 within retinal endothelial cells. Additionally, Mohammed has investigated the impact of graphene, multiwalled carbon nanotubes, and nano-sized TiO2 additives on the thermal and mechanical properties of nano-reinforced rubber composites. She has published four scholarly articles, accumulating 58 citations and an h-index of 2. Mohammed collaborates with researchers at the University of Arkansas for Medical Sciences, including Esraa Shosha, Abdelrahman Y. Fouda, Nancy J. Rusch, and Christian D. Mitchell, with whom she shares multiple publications.
Metrics
- h-index: 2
- Publications: 4
- Citations: 60
Selected Publications
-
HDAC3 mediates retinal endothelial cell metabolic reprogramming and angiogenesis (2025)
-
Role of myeloid cells in ischemic retinopathies: recent advances and unanswered questions (2024)
Collaboration Network
Top Collaborators
- Role of myeloid cells in ischemic retinopathies: recent advances and unanswered questions
- HDAC3 mediates retinal endothelial cell metabolic reprogramming and angiogenesis
- Role of myeloid cells in ischemic retinopathies: recent advances and unanswered questions
- HDAC3 mediates retinal endothelial cell metabolic reprogramming and angiogenesis
- Role of myeloid cells in ischemic retinopathies: recent advances and unanswered questions
- HDAC3 mediates retinal endothelial cell metabolic reprogramming and angiogenesis
- Role of myeloid cells in ischemic retinopathies: recent advances and unanswered questions
- HDAC3 mediates retinal endothelial cell metabolic reprogramming and angiogenesis
- Role of myeloid cells in ischemic retinopathies: recent advances and unanswered questions
- HDAC3 mediates retinal endothelial cell metabolic reprogramming and angiogenesis
- Role of myeloid cells in ischemic retinopathies: recent advances and unanswered questions
- HDAC3 mediates retinal endothelial cell metabolic reprogramming and angiogenesis
- Role of myeloid cells in ischemic retinopathies: recent advances and unanswered questions
- Role of myeloid cells in ischemic retinopathies: recent advances and unanswered questions
- Role of myeloid cells in ischemic retinopathies: recent advances and unanswered questions
- HDAC3 mediates retinal endothelial cell metabolic reprogramming and angiogenesis
- HDAC3 mediates retinal endothelial cell metabolic reprogramming and angiogenesis
- HDAC3 mediates retinal endothelial cell metabolic reprogramming and angiogenesis
Similar Researchers
Based on overlapping research topics